Novo’s Ozempic copy 15% cheaper, but Discovery still won’t change its position
Story audio is generated using AI Danish pharmaceutical manufacturer Novo Nordisk will launch its copy of its diabetes…
GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study
Drugs from the GLP-1 receptor agonist class, widely used for diabetes and weight loss, are now under scrutiny…
GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study
Drugs from the GLP-1 receptor agonist class, widely used for diabetes and weight loss, are now under scrutiny…